202 related articles for article (PubMed ID: 28885218)
1. Off-label use of medicines: The need for good practice guidelines.
Dooms M; Killick J
Int J Risk Saf Med; 2017; 29(1-2):17-23. PubMed ID: 28885218
[TBL] [Abstract][Full Text] [Related]
2. The Law and Practice of Off-Label Prescribing and Physician Promotion.
Syed SA; Dixson BA; Constantino E; Regan J
J Am Acad Psychiatry Law; 2021 Mar; 49(1):53-59. PubMed ID: 33234538
[TBL] [Abstract][Full Text] [Related]
3. Off-label Prescription of Medication.
Vrancken I
Eur J Health Law; 2015 Apr; 22(2):165-86. PubMed ID: 26399055
[TBL] [Abstract][Full Text] [Related]
4. Off-label prescription of genetically modified organism medicines in europe: emerging conflicts of interest?
Schagen FH; Hoeben RC; Hospers GA
Hum Gene Ther; 2014 Oct; 25(10):893-6. PubMed ID: 25268158
[TBL] [Abstract][Full Text] [Related]
5. [Research Status on Off-label Use in Appraisal for Medical Malpractice].
Leng BN; Wang X
Fa Yi Xue Za Zhi; 2018 Apr; 34(2):171-174. PubMed ID: 29923385
[TBL] [Abstract][Full Text] [Related]
6. Off-label prescriptions for atopic dermatitis in Europe.
Bieber T; Straeter B
Allergy; 2015 Jan; 70(1):6-11. PubMed ID: 25074686
[TBL] [Abstract][Full Text] [Related]
7. Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology.
Schrier L; Hadjipanayis A; Stiris T; Ross-Russell RI; Valiulis A; Turner MA; Zhao W; De Cock P; de Wildt SN; Allegaert K; van den Anker J
Eur J Pediatr; 2020 May; 179(5):839-847. PubMed ID: 31897842
[TBL] [Abstract][Full Text] [Related]
8. [Off-label drug use of the misoprostol in gynecology & obstetrics: From a medico-economics benefit to a potential legal risk].
Decamps-Mini D; Pelofi J; Treisser A
Gynecol Obstet Fertil; 2015 Jun; 43(6):453-8. PubMed ID: 26032707
[TBL] [Abstract][Full Text] [Related]
9. [Off-label prescription of drugs in the statutory health insurance].
Niederauer HH
Gesundheitswesen; 2010 Feb; 72(2):116-9. PubMed ID: 19894208
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
11. Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability.
Aagaard L; Kristensen K
Int J Clin Pharm; 2018 Jun; 40(3):509-512. PubMed ID: 29721740
[TBL] [Abstract][Full Text] [Related]
12. Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies.
França K; Litewka S
Int J Dermatol; 2019 Jul; 58(7):788-794. PubMed ID: 30168846
[TBL] [Abstract][Full Text] [Related]
13. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
14. [Appropriate off-label prescription in practice].
Augustin M
Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound contrast media in paediatric patients: is it an off-label use? Regulatory requirements and radiologist's liability.
Esposito F; Di Serafino M; Sgambati P; Mercogliano F; Tarantino L; Vallone G; Oresta P
Radiol Med; 2012 Feb; 117(1):148-59. PubMed ID: 21892716
[TBL] [Abstract][Full Text] [Related]
16. Off-label use of orphan medicinal products: a Belgian qualitative study.
Dooms M; Cassiman D; Simoens S
Orphanet J Rare Dis; 2016 Oct; 11(1):144. PubMed ID: 27793155
[TBL] [Abstract][Full Text] [Related]
17. [Psychiatrist's professional liability for generic, brand, and off-label drug prescription].
Nivoli G; Lorettu L
Riv Psichiatr; 2013; 48(3):215-23. PubMed ID: 23752804
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
Vilhelmsson A; Davis C; Mulinari S
PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
[TBL] [Abstract][Full Text] [Related]
19. Reasons for and frequency of off-label drug use.
Goločorbin Kon S; Iliković I; Mikov M
Med Pregl; 2015; 68(1-2):35-40. PubMed ID: 26012242
[TBL] [Abstract][Full Text] [Related]
20. No evidence or no alternative? Taking responsibility for off-label prescribing.
Ghinea N; Lipworth W; Kerridge I; Day R
Intern Med J; 2012 Mar; 42(3):247-51. PubMed ID: 22432984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
